Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Assertio Holdings, Inc. Director's Dealing 2020

May 22, 2020

34279_dirs_2020-05-21_9bac1f79-4adc-494c-8b17-783107f5d216.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Assertio Holdings, Inc. (ASRT)
CIK: 0001808665
Period of Report: 2020-05-19

Reporting Person: Tyree James L (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-19 Common Stock A 237500 Acquired 318090 Direct

Footnotes

F1: As a result of a holding company reorganization effective May 19, 2020, Assertio Holdings, Inc., is the successor issuer to Assertio Therapeutics, Inc., pursuant to 12g-3(a) of the Exchange Act.

F2: Restricted stock units that vest in full on the first anniversary of the grant date.